Live Breaking News & Updates on Nanyue Biopharming Corporation Ltd

Share this article
Share this article
ResearchAndMarkets.com s offering.
With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which has further opened up the blood product market. In 2020, the lot release volume of blood products in China sustained growth, hitting 101.31 million bottles, a year-on-year upsurge of 12.7%.
Wherein, the lot release volume of human albumin rose 14.78% on an annualized basis, making up 60%; that of human immunoglobulin (pH4) for intravenous injection as a percentage of 12.92% in the total showed a year-on-year increase of 11.78%; that of human tetanus immunoglobulin soared by 76.7% and accounted for 6.9%; other products like human fibrinogen, human prothrombin complex and human coagulation factor VIII took relatively low shares. ....

Jiangxi Boya Bio , Guangdong Shuanglin Bio , Shuanglin Bio , Laura Wood , Wuhan Zhongyuanruide Biological Products Co Ltd , Health Commission Of Yunnan Province , Hualan Biological Engineering Co Ltd , Major Enterprises , Bohui Innovation Technology , Blood Products Co Ltd , Xian Huitian Blood Products Co Ltd , Shandong Taibang Biological Products Co Ltd , Sichuan Yuanda Shuyang Pharmaceutical Co Ltd , Office Hours Call , Enterprises Make More Input , Shanxi Kangbao Biological Product Co Ltd , E St Office Hours Call , Development Trends , Guizhou Taibang Biological Products Co Ltd , Pandemic Brings Development Opportunities To Domestic Companies , Nanyue Biopharming Corporation Ltd , Chinese Academy Of Medical Sciences , Blood Product Industry Report , Health Commission , Yunnan Province , Plasma Collection Stations ,